Elagolix (ABT-620) is an oral gonadotropin-releasing hormone antagonist being studied for the treatment of endometriosis and uterine fibroids.
Type of Molecule
Small Molecule
Target
GnRH
Region
n/a
| Potential Indication | Product Type | Phase (1, 2, 3, Submitted, Approved) |
|---|---|---|
| Endometriosis | New Indication | Phase 3 |
| Uterine Fibroids | New Indication | Phase 3 |